InventisBio Co., Limited (SHA:688382)
23.60
-0.12 (-0.51%)
At close: May 23, 2025, 2:57 PM CST
InventisBio Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 1,531 | 1,586 | 1,919 | 2,235 | 724.25 | 1,032 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 1.32 | Upgrade
|
Trading Asset Securities | 101.83 | 101.3 | - | - | - | - | Upgrade
|
Cash & Short-Term Investments | 1,633 | 1,687 | 1,919 | 2,235 | 724.25 | 1,033 | Upgrade
|
Cash Growth | -11.13% | -12.10% | -14.13% | 208.62% | -29.90% | 2668.59% | Upgrade
|
Accounts Receivable | 173.59 | 165.34 | 176.57 | - | - | - | Upgrade
|
Other Receivables | 4.83 | 5.93 | 6.65 | 3.98 | 4.25 | - | Upgrade
|
Receivables | 178.42 | 171.28 | 183.21 | 3.98 | 4.25 | - | Upgrade
|
Other Current Assets | 12.23 | 11.69 | 20.46 | 26.28 | 12.95 | 5.5 | Upgrade
|
Total Current Assets | 1,823 | 1,870 | 2,123 | 2,265 | 741.45 | 1,039 | Upgrade
|
Property, Plant & Equipment | 42.61 | 44.82 | 30.38 | 47.14 | 44.02 | 8.96 | Upgrade
|
Other Intangible Assets | 0.51 | 0.59 | 0.92 | 1.25 | 0.11 | - | Upgrade
|
Long-Term Deferred Tax Assets | 3.17 | 3.44 | 2.9 | 6.22 | - | - | Upgrade
|
Long-Term Deferred Charges | - | - | 1.05 | 4.4 | 8.42 | 3.23 | Upgrade
|
Other Long-Term Assets | 3.71 | 1.86 | 3.9 | 23.35 | 6.02 | 6.05 | Upgrade
|
Total Assets | 1,873 | 1,921 | 2,162 | 2,348 | 800.03 | 1,057 | Upgrade
|
Accounts Payable | 54.57 | 59.96 | 72.52 | 62.25 | 64.22 | 30.57 | Upgrade
|
Accrued Expenses | 19.74 | 21.62 | 28.86 | 36.19 | 25.71 | 13.68 | Upgrade
|
Current Portion of Leases | 4.16 | 7.79 | 9 | 12.07 | 8.71 | - | Upgrade
|
Current Unearned Revenue | - | - | 47.17 | - | - | - | Upgrade
|
Other Current Liabilities | 2 | 0.61 | 0.72 | 0.51 | 0.22 | 1.64 | Upgrade
|
Total Current Liabilities | 80.7 | 89.98 | 158.27 | 111.02 | 98.85 | 45.89 | Upgrade
|
Long-Term Leases | 18.71 | 16.13 | 2.61 | 15.27 | 14.94 | - | Upgrade
|
Long-Term Unearned Revenue | 0.48 | 0.48 | 0.88 | 0.4 | 1.2 | 0.8 | Upgrade
|
Long-Term Deferred Tax Liabilities | 3.17 | 3.44 | 2.9 | 6.22 | - | - | Upgrade
|
Total Liabilities | 103.05 | 110.03 | 164.67 | 132.9 | 115 | 46.69 | Upgrade
|
Common Stock | 578.33 | 576.75 | 575 | 575 | 460 | 460 | Upgrade
|
Additional Paid-In Capital | 3,807 | 3,791 | 3,738 | 3,671 | 1,773 | 1,740 | Upgrade
|
Retained Earnings | -2,602 | -2,545 | -2,305 | -2,021 | -1,537 | -1,179 | Upgrade
|
Comprehensive Income & Other | -12.4 | -11.9 | -10.74 | -10.4 | -10.79 | -10.05 | Upgrade
|
Shareholders' Equity | 1,770 | 1,811 | 1,998 | 2,215 | 685.03 | 1,010 | Upgrade
|
Total Liabilities & Equity | 1,873 | 1,921 | 2,162 | 2,348 | 800.03 | 1,057 | Upgrade
|
Total Debt | 22.87 | 23.92 | 11.62 | 27.34 | 23.66 | - | Upgrade
|
Net Cash (Debt) | 1,610 | 1,663 | 1,908 | 2,208 | 700.6 | 1,033 | Upgrade
|
Net Cash Growth | -11.87% | -12.82% | -13.59% | 215.14% | -32.20% | 2668.59% | Upgrade
|
Net Cash Per Share | 2.82 | 2.89 | 3.32 | 4.34 | 1.53 | 2.25 | Upgrade
|
Filing Date Shares Outstanding | 578.33 | 576.75 | 575 | 575 | 460 | 460 | Upgrade
|
Total Common Shares Outstanding | 578.33 | 576.75 | 575 | 575 | 460 | 460 | Upgrade
|
Working Capital | 1,743 | 1,780 | 1,965 | 2,154 | 642.6 | 992.85 | Upgrade
|
Book Value Per Share | 3.06 | 3.14 | 3.47 | 3.85 | 1.49 | 2.20 | Upgrade
|
Tangible Book Value | 1,770 | 1,810 | 1,997 | 2,214 | 684.92 | 1,010 | Upgrade
|
Tangible Book Value Per Share | 3.06 | 3.14 | 3.47 | 3.85 | 1.49 | 2.20 | Upgrade
|
Machinery | - | 32.55 | 32.04 | 27.07 | 23.91 | 6.51 | Upgrade
|
Construction In Progress | - | 6.47 | 0.5 | 2.58 | 1.87 | 3.88 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.